|
1
|
Wu JQ, Seymour JF, Eichhorst B, Hillmen P, Kipps T, Langerak AW, Owen C, Dubois J, Mellink C, van der Kevie‐Kersemaekers A, Chyla B, Jiang Y, Boyer M, Thadani‐Mulero M, Lefebure M, Kater AP. UNFAVORABLE GENETICS IMPACT MRD RESPONSE TO VENETOCLAX+RITUXIMAB RETREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): PHASE 3 MURANO SUBSTUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.50_2880] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- J. Q. Wu
- Genentech, Inc Oncology Biomarker Development South San Francisco USA
| | - J. F. Seymour
- Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne Department of Haematology Melbourne Australia
| | - B. Eichhorst
- University of Cologne Department I of Internal Medicine and Center of Integrated Oncology Aachen Cologne Germany
| | - P. Hillmen
- St. James’s University Hospital Department of Haematology Leeds UK
| | - T. Kipps
- UC San Diego Health, Moores Cancer Center San Diego USA
| | - A. W. Langerak
- University Medical Center Department of Hematology Rotterdam Netherlands
| | - C. Owen
- University of Calgary Departments of Medicine and Oncology Calgary Canada
| | - J. Dubois
- Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam Department of Hematology Amsterdam Netherlands
| | - C. Mellink
- Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam Department of Hematology Amsterdam Netherlands
| | - A. van der Kevie‐Kersemaekers
- Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam Department of Hematology Amsterdam Netherlands
| | - B. Chyla
- AbbVie Inc. Cancer Biomarkers North Chicago USA
| | - Y. Jiang
- Genentech, Inc Oncology Biomarker Development South San Francisco USA
| | - M. Boyer
- Roche Products Limited Clinical Science Welwyn Garden City UK
| | | | - M. Lefebure
- Roche Products Limited Clinical Science Welwyn Garden City UK
| | - A. P. Kater
- Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam Department of Hematology Amsterdam Netherlands
| |
Collapse
|